BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8702909)

  • 1. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma.
    Avidor-Reiss T; Nevo I; Levy R; Pfeuffer T; Vogel Z
    J Biol Chem; 1996 Aug; 271(35):21309-15. PubMed ID: 8702909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits.
    Belcheva MM; Vogel Z; Ignatova E; Avidor-Reiss T; Zippel R; Levy R; Young EC; Barg J; Coscia CJ
    J Neurochem; 1998 Feb; 70(2):635-45. PubMed ID: 9453557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.
    Chan JS; Chiu TT; Wong YH
    J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
    Carter BD; Medzihradsky F
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
    Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
    Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment.
    Avidor-Reiss T; Bayewitch M; Levy R; Matus-Leibovitch N; Nevo I; Vogel Z
    J Biol Chem; 1995 Dec; 270(50):29732-8. PubMed ID: 8530363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.
    Niroomand F; Mura RA; Piacentini L; Kübler W
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):643-9. PubMed ID: 8938664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of G(i/o)-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation.
    Bayewitch ML; Nevo I; Avidor-Reiss T; Levy R; Simonds WF; Vogel Z
    Mol Pharmacol; 2000 Apr; 57(4):820-5. PubMed ID: 10727531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition and superactivation of the calcium-stimulated isoforms of adenylyl cyclase: role of Gbetagamma dimers.
    Steiner D; Avidor-Reiss T; Schallmach E; Saya D; Vogel Z
    J Mol Neurosci; 2005; 27(2):195-203. PubMed ID: 16186630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling.
    Cheng ZJ; Yu QM; Wu YL; Ma L; Pei G
    J Biol Chem; 1998 Sep; 273(38):24328-33. PubMed ID: 9733719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
    Yoshimura M; Ikeda H; Tabakoff B
    Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunit-mediated effect?
    Khasar SG; Wang JF; Taiwo YO; Heller PH; Green PG; Levine JD
    Neuroscience; 1995 Jul; 67(1):189-95. PubMed ID: 7477899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
    Izenwasser S; Búzás B; Cox BM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively active mu-opioid receptors inhibit adenylyl cyclase activity in intact cells and activate G-proteins differently than the agonist [D-Ala2,N-MePhe4,Gly-ol5]enkephalin.
    Liu JG; Ruckle MB; Prather PL
    J Biol Chem; 2001 Oct; 276(41):37779-86. PubMed ID: 11500514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase.
    Fedynyshyn JP; Lee NM
    FEBS Lett; 1989 Aug; 253(1-2):23-7. PubMed ID: 2547657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of mu-, delta- and kappa-opioid receptors in baculovirus-infected insect cells.
    Obermeier H; Wehmeyer A; Schulz R
    Eur J Pharmacol; 1996 Dec; 318(1):161-6. PubMed ID: 9007528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate-induced adenylyl cyclase superactivation is isozyme-specific.
    Avidor-Reiss T; Nevo I; Saya D; Bayewitch M; Vogel Z
    J Biol Chem; 1997 Feb; 272(8):5040-7. PubMed ID: 9030567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB(1) cannabinoid receptor.
    Rhee MH; Nevo I; Avidor-Reiss T; Levy R; Vogel Z
    Mol Pharmacol; 2000 Apr; 57(4):746-52. PubMed ID: 10727521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.